Research News

Macrophage Signatures that Help Predict Lymphoma Patient’s Survival Rate

Macrophages are “big eaters” in our body; they are immune cells that engulf and kill invading organisms and cancer cells. Macrophages are present in the living ecosystem of many types of cancer. Using digital imaging, bioinformatics, and machine learning techniques, research led by N2CR member, Dr Anand Jeyasekharan, discovered 6 different macrophage signatures (MacroSigs) that can help distinguish types of macrophages in normal lymph nodes and diffuse large B-cell lymphoma (DLBCL), a tumour arising from our lymph nodes. This groundbreaking discovery helps doctors understand the evolution of this disease and how some DLBCL tumours relapse after chemotherapy. 

Read more: https://www.nature.com/articles/s41467-024-46220-z

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Extracellular Vesicles: Key Players in Tumour Microenvironment and Drug Resistance

This research, led by N2CR members Prof Goh Boon Cher and Prof Shazib Pervaiz with Dr Jayshree Hirpara as the …

Read More →
Research News

DriverDetect Software: Enhancing Cancer Mutation Prediction with Machine Learning

Detecting cancer-driving mutations is crucial for understanding cancer and developing treatments. Existing prediction tools vary in accuracy. N2CR member A/Prof …

Read More →
Research News

Understanding RNA Changes and Cancer Development

Led by N2CR member A/Prof Polly Chen, this research highlights the crucial role of ‘death associated protein 3’ (DAP3) in …

Read More →